These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11353602)

  • 1. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.
    Aubert D; Poirel L; Chevalier J; Leotard S; Pages JM; Nordmann P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1615-20. PubMed ID: 11353602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo selection of oxacillinase-mediated ceftazidime resistance in Pseudomonas aeruginosa.
    Leotard S; Poirel L; Leblanc PE; Nordmann P
    Microb Drug Resist; 2001; 7(3):273-5. PubMed ID: 11759089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N; Hiruma R; Katsu K
    J Antimicrob Chemother; 1992 Nov; 30(5):633-41. PubMed ID: 1493980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime.
    Campo Esquisabel AB; Rodríguez MC; Campo-Sosa AO; Rodríguez C; Martínez-Martínez L
    Clin Microbiol Infect; 2011 Dec; 17(12):1817-22. PubMed ID: 21599797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand.
    Girlich D; Naas T; Leelaporn A; Poirel L; Fennewald M; Nordmann P
    Clin Infect Dis; 2002 Mar; 34(5):603-11. PubMed ID: 11807680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integron-located oxa-32 gene cassette encoding an extended-spectrum variant of OXA-2 beta-lactamase from Pseudomonas aeruginosa.
    Poirel L; Gerome P; De Champs C; Stephanazzi J; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2002 Feb; 46(2):566-9. PubMed ID: 11796380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.
    Tawfik AF; Shibl AM; Aljohi MA; Altammami MA; Al-Agamy MH
    Burns; 2012 Sep; 38(6):855-60. PubMed ID: 22348803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.
    Arca-Suárez J; Fraile-Ribot P; Vázquez-Ucha JC; Cabot G; Martínez-Guitián M; Lence E; González-Bello C; Beceiro A; Rodríguez-Iglesias M; Galán-Sánchez F; Bou G; Oliver A
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiprole.
    Queenan AM; Shang W; Bush K; Flamm RK
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4092-7. PubMed ID: 20606064
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Fraile-Ribot PA; Mulet X; Cabot G; Del Barrio-Tofiño E; Juan C; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa.
    Danel F; Hall LM; Livermore DM
    J Antimicrob Chemother; 1999 Mar; 43(3):339-44. PubMed ID: 10223588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
    Hocquet D; Colomb M; Dehecq B; Belmonte O; Courvalin P; Plésiat P; Meziane-Cherif D
    J Antimicrob Chemother; 2011 Aug; 66(8):1745-50. PubMed ID: 21665906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of extended spectrum β-lactamase OXA-141 in Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    González-Villa M; Ribas-Aparicio RM; Coria-Jiménez R; Donis-Rocandio JE; Aparicio-Ozores G
    Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):535-41. PubMed ID: 22365474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene.
    Poirel L; Girlich D; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2001 Feb; 45(2):447-53. PubMed ID: 11158739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.
    Fung-Tomc J; Dougherty TJ; DeOrio FJ; Simich-Jacobson V; Kessler RE
    Antimicrob Agents Chemother; 1989 Apr; 33(4):498-502. PubMed ID: 2499250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
    Pournaras S; Maniati M; Spanakis N; Ikonomidis A; Tassios PT; Tsakris A; Legakis NJ; Maniatis AN
    J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
    Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
    J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates.
    Lin SP; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2012 Jun; 45(3):200-7. PubMed ID: 22209695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.